Evidence map›Paper›PMID 41824409›Full record

ArticlePloS one2026

Development of InDel markers associated with leaf protein content in mulberry based on whole-genome resequencing.

Jiaqi Li, Zijing Shen, Qin Zhang, Jianguo Shi, Fugui Jia, Yumei Liu, Huiping Luo, Rou Zhang

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiaqi LiYulin University, Yulin, China.ORCID https://orcid.org/0009-0002-9895-6686
Zijing ShenYulin University, Yulin, China.
Qin ZhangYulin University, Yulin, China.
Jianguo ShiYulin University, Yulin, China.
Fugui JiaYulin University, Yulin, China.
Yumei LiuYulin University, Yulin, China.
Huiping LuoYulin University, Yulin, China.
Rou ZhangYulin University, Yulin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mulberry (Morus alba L.), as a crucial dual-purpose crop for medicinal and forage applications, requires genetic improvement of leaf protein content to substantially enhance its feed value. This study utilized 46 mulberry germplasms as test materials, with 29 accessions subjected to whole-genome resequencing on the Illumina HiSeq platform. Based on the resequencing data, Indel primers were designed and screened to analyze genetic diversity and develop Indel markers tightly linked to crude protein content in mulberry leaves. The results showed that a total of 1 155 585 InDel loci were detected in the 29 accessions, with 11 401 InDels located in coding regions (0.99%). Analysis of functional annotations in extreme-phenotype germplasm revealed that 2 563 InDel-containing genes within coding sequence (CDS) regions of high-protein accessions were significantly enriched in catalytic activity and metabolic processes. Further utilizing InDel variations within CDS regions, 98 pairs of InDel primers were designed, yielding a novel linked marker (Chr1-3-204) with distinct amplification patterns between high- and low-protein accessions. Validation in 46 accessions showed 89.1% accuracy (r = 0.726, P < 0.01). Sanger sequencing confirmed its high accuracy (97.7% similarity to reference), with 84% identity to Morus motabilis. This study is the first to develop a linked marker for crude protein content in mulberry leaves, providing a technical reference for the breeding of high-protein mulberry varieties.N.

Indexed as

Genome, PlantINDEL MutationMorusPlant LeavesPlant ProteinsGenetic MarkersWhole Genome SequencingGenetic MarkersPlant Proteins

Identifiers

PMID41824409
PMCPMC12987496

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.